Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;25(3):218-230.
doi: 10.1097/MOT.0000000000000755.

Cardiomyopathies in children: classification, diagnosis and treatment

Giulia De Angelis  1 , Marco Bobbo  2 , Alessia Paldino  1 , Biancamaria D'Agata Mottolese  2 , Alessandro Altinier  1 , Matteo Dal Ferro  1 , Marco Merlo  1 , Gianfranco Sinagra  1
Affiliations
Review

Cardiomyopathies in children: classification, diagnosis and treatment

Giulia De Angelis et al. Curr Opin Organ Transplant. 2020 Jun.

Abstract

Purpose of review: Cardiomyopathies are rare in the pediatric population, but significantly impact on morbidity and mortality. The present review aims to provide an overview of cardiomyopathies in children and some practical guidelines for their prognostic stratification and management.

Recent findings: Pediatric cardiomyopathies may present as isolated cardiac muscle disease or in the context of complex clinical syndromes. The etiologic characterization represents an important step in the diagnosis and treatment of cardiomyopathies because of its impact on prognosis and on therapeutic measures. Indeed, replacement therapy is nowadays widely available and changes the natural history of the disease. More complex is the management of isolated cardiomyopathies, which lack specific therapies, mainly aimed at symptomatic relief. In this context, heart transplantation shows excellent outcomes in children, but wait-list mortality is still very high. Device therapy for sudden cardiac death prevention and the use of mechanical assist devices are becoming more common in the clinical practice and may help to reduce mortality.

Summary: Providing insight into pediatric cardiomyopathies classification helps in the prognostication and management of such diseases. Recent years witnessed a significant improvement in mortality, but future research is still needed to improve quality of life and life expectations in the pediatric population.

PubMed Disclaimer

References

    1. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008; 29:270–276.
    1. Maron BJ, Towbin JA, Thiene S G., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Function. Circulation 2006; 113:1807–1816.
    1. Lee TM, Hsu DT, Kantor P, et al. Pediatric cardiomyopathies. Circ Res 2017; 121:855–873.
    1. Griffin L, Martin C, Bolman RM, et al. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol 1988; 11:139–144.
    1. Rossano JW, Shaddy RE. Heart failure in children: etiology and treatment. J Pediatr 2014; 165:228–233.